Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endocannabinoids in Hypnosis and Meditation Analgesia
NCT03407937Completed
- Sponsor
- Université de Sherbrooke
- Start
- Nov 2017
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Single-blind, single-arm trial, sponsored by Université de Sherbrooke. Primary endpoint: Plasma concentrations of endocannabinoids. Started Nov 2017; status: completed.
Beyond the preview
Go deeper on NCT03407937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03407937.